EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

If there's one thing we can say about the Trump administration, whether one agrees with his policies or not, it's that he's an incredibly active president who generates a lot of news. This has likely been a blessing for The NewWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regular contributor on ...

Uncle Sam may have just launched the most unconventional ETF on Wall Street (hypothetical, of course). With equity stakes in Intel Corp (NASDAQ:INTC) and Lithium Americas Corp (NYSE:LAC), the U.S. government is shifting from backroom subsidies to front-row ownership — and investors are taking notice.Track INTC stock here.In recent weeks, President Donald Trump‘s administration finalized a nearly 10% stake in Intel, restructuring $8.9 billion in CHIPS Act grants into common stock, and took a 5% equity positi ...

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?I last covered Atai Life Sciences N.V. (NASDAQ: ATAI ) for Seeking Alpha back in July, giving its stock a Buy rating. A good decision, as it has turned out, given Atai stock now trades at $5.2 perThe group is for b ...

But when the government shut down at midnight Wednesday morning, it marked the first closure since early 2019, which was the longest in history at 35 days. Republicans and Democratic lawmakers are deadlocked as Democrats refuse to vote on a bill that wouldn't extend health care subsidies set to expire at the end of the year, subsidies that are necessary to stave off dramatic increases in health care prices for millions of Americans. Republicans won't negotiate or vote on Democrats' alternative legislation. ...

If you tell Amex you want to cancel, the company might offer you some cash, points or miles as an incentive to keep your card. ...

Despite the job losses reported by ADP, the economic picture isn't so scary. Here are three ETFs that offer exposure to areas of growth, according to Sevens Report's Tom Essaye. ...

Shares of Glaukos Corporation (NYSE:GKOS) inched higher on Wednesday after Goldman Sachs initiated its coverage with a Buy recommendation and a $103 per share target, citing a compelling valuation setup. Analyst David Roman argued that the consensus estimates and the ...

LOS ANGELES--(BUSINESS WIRE)---- $MLTX--MLTX Investors Have Opportunity to Join MoonLake Immunotherapeutics Fraud Investigation with the Schall Law Firm. ...

SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- A new securities class action lawsuit has been filed against KinderCare Learning Companies, Inc. (NYSE: KLC) and its executives, alleging the company misled investors during its October 2024 Initial Public Offering (IPO). The lawsuit, styled Gollapalli v. KinderCare Learning Companies, Inc., et al., seeks to represent investors who purchased KLC common stock in or traceable to the company’s IPO. The lawsuit claims that KinderCare’s IPO documents painted a fal ...